ARCHIVES

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

This article is from The Cancer Letter archive.

Vol. 40 No. 04 | January 24, 2014

Download PDF Visit The Full Archive

Related Articles

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Funding Opportunities: NIH seeks “visionary thinkers” for awards of $2.5 million over five years. NCI RFA available.

January 23, 2004

Clinton To Propose $1 Billion Increase And A New Minority Health Center For NIH.

January 21, 2000

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005